News & Insights
Cascadia Capital Provides Advisory Services and Fairness Opinion to Publicly Traded Bioengineering Company
Cascadia Capital, an investment bank serving middle market clients globally, is pleased to have acted as the financial advisor to Intrexon Corporation (NASDAQ: XON) in the transactions noted below.
Intrexon Corporation, a publicly traded bioengineering and biopharmaceutical company, engaged Cascadia Capital to provide transaction advisory services in its divesture of a stake in AquaBounty Technologies, LLC (NASDAQ: AQB), a genetically modified salmon producer. The sale took place on October 29th, 2019 as announced in Intrexon’s public filings.
The Special Committee of the Board of Directors of Intrexon engaged Cascadia Capital to provide a fairness opinion in connection with the divestiture.